# US 2022/0017953 A1 · Parallelized sample processing and library prep

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0017953 A1
- Document ID: US20220017953A1
- Status: Published application
- Kind: A1
- Application number: 17/333,792
- Filed: 2021-05-28
- Published: 2022-01-20
- Earliest claimed: 2020-02-20
- Assignees: Fluidigm Corporation
- Applicants: Fluidigm Corporation
- Inventors: Michael L. Phelan; Christopher J. Kubu; Brian Fowler; Gang Sun; Nikita Patel; Naveen Ramalingam
- Web page: https://patentgrep.com/patent/US20220017953A1

## CPC

- C12Q 1/6851: Quantitative amplification
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Described herein are methods, kits and systems for sample enrichment, multi-step library preparation, sample normalization, detection of sample biomolecules and combinations thereof. Enrichment and multi-step library preparation is described in the context of microfluidic workflows. Sample barcoding methods and kits are described for increasing sample throughput while reducing background in negative samples. Integrated microfluidic devices comprising sample processing unit cells coupled to an array of reaction sites are provided for integrated workflows.

## Claims

### Claim at position 1

1-247. (canceled)

### Claim 248

A method of detecting the presence of at least one of a plurality of alleles of a gene in a sample, the method comprising:
a) preamplifying a gene by PCR to obtain a preamplified sample such that a plurality of alleles of the gene would be amplified by the same preamplification primer pair;
b) separating the preamplified sample into a plurality of reaction sites; and
c) detecting a cycle threshold (CT) of each of the plurality of alleles in a separate reaction site of the plurality of reaction sites, wherein detection is by qPCR and wherein each allele is specifically amplified with a different allele-specific primer pair.

### Claim at position 3

249-250. (canceled)

### Claim 251 (depends on 248)

The method of claim 248, wherein at least step b) and c) are performed on a microfluidic device, wherein the microfluidic device comprises an array of reaction sites, wherein individual reaction sites of the array of reaction sites comprises an assay chamber and a sample chamber; and wherein sample inlets provide sample to the sample chambers and assay inlets provide assay reagents to the assay chambers

### Claim 252

(canceled)

### Claim 253 (depends on 248)

The method of claim 248, wherein at least one of step a), b) and c) is performed on a microfluidic device wherein the microfluidic device comprises: an array of reaction sites; and a plurality of sample processing unit cells comprising a plurality of sample processing sites, wherein the unit cell is in fluidic communication with a plurality of different reagent inlets; wherein sample inlets to the array are downstream of the plurality of sample processing sites of the plurality of unit cells.

### Claim 254 (depends on 253)

The method of claim 253, wherein the microfluidic device comprises a column configured to retain beads.

### Claim 255 (depends on 254)

The method of claim 254, wherein the gene is a viral gene, and further comprising capturing a viral RNA sequence of the gene on the beads through hybridization to a ssDNA sequence prior to step a).

### Claim 256 (depends on 255)

The method of claim 255, further comprising eluting the viral RNA sequence and preamplifying the eluted viral RNA sequence to produce a cDNA sequence of the gene prior to step a) of preamplifying.

### Claim 257 (depends on 256)

The method of claim 256, further comprising reverse transcribing the viral RNA sequence captured on the beads to produce a cDNA sequence of the gene prior to step a) of preamplifying.

### Claim 258 (depends on 254)

The method of claim 254, further comprising capturing viral particles of the sample with antibody conjugated to the beads prior to step a), wherein the gene is a viral gene.

### Claim 259

(canceled)

### Claim 260 (depends on 248)

The method of claim 248, wherein the gene is a viral gene, the method further comprising reverse transcription of viral RNA to produce a cDNA sequence of the gene prior to step a) of preamplifying.

### Claim 261 (depends on 259)

The method of claim 259, wherein the gene is a viral gene, and the sample is a SARS-CoV-2 sample.

### Claim 262 (depends on 248)

The method of claim 248, wherein one allele has a single nucleotide polymorphism compared to another allele and is amplified in step c) with an allele-specific primer pair that is specific to a point mutation.

### Claim 263 (depends on 248)

The method of claim 248, wherein one allele has an insertion or deletion compared to another allele and is amplified in step c) with an allele-specific primer pair that is specific to the insertion or deletion.

### Claim 264 (depends on 248)

The method of claim 248, wherein the sample is a biological sample such as a blood sample, saliva, a nasal swab, or derived from solid tissue.

### Claim 265 (depends on 248)

The method of claim 248, further comprising detecting the presence of at least 4 alleles,

### Claim 266

(canceled)

### Claim 267 (depends on 248)

The method of claim 248, wherein qPCR of the alleles in step c) uses the same probe across the plurality of reaction sites in which different alleles of the gene are detected.

### Claim 268

(canceled)

### Claim 269 (depends on 267)

The method of claim 267, wherein the probe specifically hybridizes to a sequence of the gene conserved across the different alleles.

### Claim 270 (depends on 248)

The method of claim 248, wherein step a) of preamplifying further comprises amplifying additional genes with additional preamplification primer pairs.

### Claim 271 (depends on 270)

The method of claim 270, wherein the additional primer pairs include a primer pair specific for the SARS-CoV-2 N1 gene or the SARS-CoV-2 N2 gene.

### Claim 272 (depends on 248)

The method of claim 248, wherein the alleles include at least two SARS-CoV-2 spike S1 alleles.

### Claim 273 (depends on 248)

The method of claim 248, wherein at least one allele is amplified in step c) with two allele-specific primers specific for different variant sites of the allele.

### Claim 274 (depends on 248)

The method of claim 248, wherein at least two alleles are amplified in step c) with the same reverse primer or the same forward primer.

### Claim 275 (depends on 248)

The method of claim 248, further comprising step d) of identifying the presence of an allele in the sample based on a difference in the CT values (dCT) of the allele and another allele of the plurality of alleles.

### Claim 276 (depends on 275)

The method of claim 275, wherein the plurality of alleles comprises at least one wildtype allele and two or more mutant alleles.

### Claim 277 (depends on 276)

The method of claim 276, wherein the presence of each of the mutant alleles is identified in step d) based on whether a dCT between the wildtype allele and the mutant allele is above or below a predetermined dCT threshold.

### Claim 278 (depends on 275)

The method of claim 275, wherein the predetermined dCT threshold is greater than 3 or less than −3.

### Claim 279

(canceled)

### Claim 280 (depends on 275)

The method of claim 275, wherein the presence of a mutant allele is identified in step d) and the mutant allele is present at 10% or less of a wildtype allele in the sample.

### Claim 281 (depends on 275)

The method of claim 275, further comprising identifying the presence of a virus based on detection of one or more additional genes preamplified in step a) and detected by qPCR in step c).

### Claim 282 (depends on 281)

The method of claim 281, further comprising identifying a viral load based on the CT of one or more additional genes preamplified in step a) and detected by qPCR in step c).

### Claim 283 (depends on 280)

The method of claim 280, wherein the one or more additional genes comprise at least one of the SARS-CoV-2 N1 gene and the SARS-CoV-2 N2 gene.

### Claim 284 (depends on 275)

The method of claim 275, wherein the CT value of at least one of the alleles of the plurality of alleles is used to report a viral load, wherein the gene is a viral RNA gene.

### Claim at position 38

285-306. (canceled)
